MGTX MeiraGTx Holdings plc

12.76
+0.32  (+3%)
Previous Close 12.44
Open 12.48
Price To Book 3.62
Market Cap 349453424
Shares 27,386,632
Volume 304,707
Short Ratio
Av. Daily Volume 92,066

SEC filingsSee all SEC filings

  1. 8-K - Current report 19625723
  2. SC 13G - Statement of acquisition of beneficial ownership by individuals 19579911
  3. 8-K - Current report 19568822
  4. 8-K - Current report 19564103
  5. 8-K - Current report 181246593

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 1/2 trial to be initiated 1H 2019.
AAV-AQP1
Xerostomia
Phase 1/2 data 1Q 2019.
AAV-RPE65
RPE65-Deficiency
Phase 1/2 data mid-2019.
AAV-RPGR
X-Linked Retinitis Pigmentosa
Phase 1/2 trial to be initiated 2H 2019.
AAV-CNGA3
Achromatopsia
Phase 1/2 data due 3Q 2019.
AAV-CNGB3
Achromatopsia

SEC Filings

  1. 8-K - Current report 19625723
  2. SC 13G - Statement of acquisition of beneficial ownership by individuals 19579911
  3. 8-K - Current report 19568822
  4. 8-K - Current report 19564103
  5. 8-K - Current report 181246593
  6. 10-Q - Quarterly report [Sections 13 or 15(d)] 181170053
  7. 8-K - Current report 181168307
  8. 8-K - Current report 181112319
  9. 8-K - Current report 181112158
  10. 10-Q - Quarterly report [Sections 13 or 15(d)] 181001687